We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
926
DELISTED
New Gold Inc
NGD
| $1.59M | ﹤0.01% |
1,626,138
+1,408,096
| +646% | +$1.42M |
|
927
Sterling Infrastructure
STRL
$16.9B
| $1.59M | ﹤0.01% |
48,498
+12,996
| +37% | +$382K |
|
928
J. Jill
JILL
$283M
| $1.59M | ﹤0.01% |
64,056
+48,659
| +316% | +$1.08M |
|
929
Tencent Music
TME
$14.2B
| $1.57M | ﹤0.01% |
190,248
+89,109
| +88% | +$501K |
|
930
Avantor
AVTR
$9.37B
| $1.57M | ﹤0.01% |
74,558
+5,201
| +7% | +$108K |
|
931
Innoviva
INVA
$1.5B
| $1.56M | ﹤0.01% |
+118,130
| New | +$1.55M |
|
932
Archer Daniels Midland
ADM
$38.6B
| $1.56M | ﹤0.01% |
+16,803
| New | +$1.55M |
|
933
Xperi
XPER
$320M
| $1.56M | ﹤0.01% |
+181,012
| New | +$2.07M |
|
934
PLDT
PHI
$4.2B
| $1.55M | ﹤0.01% |
67,939
+46,570
| +218% | +$1.23M |
|
|
TCS
935
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $1.54M | ﹤0.01% |
23,904
+3,913
| +20% | +$283K |
|
|
RUTH
936
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.54M | ﹤0.01% |
99,763
-261,556
| -72% | -$4.59M |
|
|
NOA
937
North American Construction
NOA
$389M
| $1.54M | ﹤0.01% |
+115,192
| New | +$1.42M |
|
938
Thryv Holdings
THRY
$96.9M
| $1.53M | ﹤0.01% |
80,757
-29,831
| -27% | -$582K |
|
939
Nordic American Tanker
NAT
$1.4B
| $1.52M | ﹤0.01% |
498,245
+460,103
| +1,206% | +$1.48M |
|
940
Trustmark
TRMK
$2.8B
| $1.51M | ﹤0.01% |
43,400
-6,204
| -13% | -$217K |
|
941
Vertex Pharmaceuticals
VRTX
$131B
| $1.51M | ﹤0.01% |
5,233
+141
| +3% | +$43K |
|
942
CME Group
CME
$96.1B
| $1.49M | ﹤0.01% |
8,853
+6,821
| +336% | +$1.19M |
|
943
Covenant Logistics
CVLG
$880M
| $1.48M | ﹤0.01% |
85,856
-53,616
| -38% | -$961K |
|
944
Standex International
SXI
$3.97B
| $1.48M | ﹤0.01% |
14,417
-14,460
| -50% | -$1.42M |
|
945
Turkcell
TKC
$4.72B
| $1.48M | ﹤0.01% |
308,011
-198,270
| -39% | -$778K |
|
946
Enviri
NVRI
$564M
| $1.47M | ﹤0.01% |
234,367
+42,035
| +22% | +$251K |
|
947
Fortuna Silver Mines
FSM
$3.1B
| $1.47M | ﹤0.01% |
+391,754
| New | +$1.29M |
|
948
Progress Software
PRGS
$1.83B
| $1.46M | ﹤0.01% |
28,962
+3,400
| +13% | +$170K |
|
949
Unilever
UL
$135B
| $1.46M | ﹤0.01% |
25,751
-780,728
| -97% | -$41.8M |
|
|
NVO
950
Novo Nordisk
NVO
$205B
| $1.45M | ﹤0.01% |
21,440
-33,238
| -61% | -$1.95M |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.